What is Good-Lite?
Established in 1930, Good-Lite has evolved into a premier manufacturer and distributor of high-precision vision screening and testing instruments. The company is widely recognized for its proprietary Lea Test System, which serves as a gold standard for assessing visual acuity, contrast sensitivity, and color vision in clinical settings. By integrating traditional diagnostic craftsmanship with modern medical requirements, Good-Lite maintains a critical role in the healthcare supply chain, providing essential tools for pediatric and adult vision assessment across international markets.
How much funding has Good-Lite raised?
Good-Lite has raised a total of $349K across 2 funding rounds:
Debt
$150K
Debt
$199K
Debt (2020): $150K with participation from PPP
Debt (2021): $199K led by PPP
Key Investors in Good-Lite
PPP
Public-Private Partnership
What's next for Good-Lite?
With this late-stage capital infusion, Good-Lite is positioned to accelerate its operational scaling and potentially expand its diagnostic portfolio. The strategic focus will likely center on enhancing the distribution of its LEA Symbols and LEA Numbers systems while exploring new technological integrations for cortical visual assessment. As the company navigates this growth phase, the emphasis remains on maintaining its legacy of clinical accuracy while adapting to the increasing demand for sophisticated, high-contrast vision testing solutions in both clinical and research environments.
See full Good-Lite company page
